Study of F527 in Patients With Relapsed or Refractory Lymphoma
Clinical trial NCT05293028 · UNKNOWN
Trial details
- NCT number
- NCT05293028
- Sponsor
- Shandong New Time Pharmaceutical Co., LTD
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-20
- Primary completion
- 2023-11-20
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.